Safety and efficacy of oral slow release morphine for the maintenance therapy for opioid dependence - Results of a pilot study in outpatients;Wirksamkeit und verträglichkeit von oralem retardierten morphin für die substitutionstherapie von opiatabhängigen: Ergebnisse einer pilotstudie an ambulanten patienten

Suchtmedizin in Forschung und Praxis

Volumn 7, Issue 3, 2005, Pages 215-220

  Hermann, Peter ^a   Wagner, Walter ^b   Lindenbauer, Bernhard ^c  

^a Wiener Krankenanstaltenverbund   (Austria)

^b Landeskrankenhaus Klagenfurt   (Austria)

^c KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Maintenance therapy; Opioid addicts; Oral slow release morphine

Indexed keywords

MORPHINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; MAINTENANCE THERAPY; OPIATE ADDICTION; OUTPATIENT CARE; PSYCHOMETRY; SLOW RELEASE FORMULATION; WITHDRAWAL SYNDROME;

EID: 26944497606     PISSN: 14375567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cherny NI, Portenoy RK (1994): Practical issues in the management of cancer pain. In: Wall PD, Melzack R (Hrsg.):Textbook of Pain, Churchill Livingstone, Edinburgh, S 1437-1467
2. Derogatis LR (1996): Symptom-Checkliste Selbstbeurteilungs-Skala, Self-Report Symptom Inventory 90 Items- revised, vormals Hopkins Symptom Checklist. In: Collegium Internationale Psychiatriae Scalarum, (Hrsg.): Internationale Skalen für Psychiatrie, 4. Auflage, Beltz-Test GmbH, Göttingen, S 161-167
3. Eder H, Jagsch R, Kraigher D, Primorac A, Ebner N, Fischer G (2005): Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction 100, 1101-1109
4. EMCDDA, European Monitoring Centre for Drugs and Drug Addiction (2002):Key role of substitution in drug treatment. Drugs in focus, Nr. 1. www.emcdda.eu.int → Publications → Drugs in focus
5. EMCDDA, European Monitoring Centre for Drugs and Drug Addiction (2004): The EU action plan on drugs (2000-2004). www.emcdda.eu.int/ /?nnodeid=1338
6. Fischer G, Presslich O, Diamant K, Schneider C, Pezawas L, Kasper S (1996): Oral morphine-sulphate in the treatment of opiate dependent patients. Alcoholism 32, 35-43
7. Fischer G, Jagsch R, Eder H, Gombas W, Etzersdorfer P, Schmidl-Mohl K, et al. (1999):Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 94, 231-239
8. Gossop M (2003): Randomised and controlled, but irrelevant? In: Helge Waal, Egil Haga (Hrsg.): Maintenance treatment of heroin addiction. Cappelen Akademisk Forlag, Oslo, S 91-105
9. o) in cancer pain. J Pain Symptom Manage 29, 80-90
10. Hautzinger M, Bailer M, Worrall H, Keller F (2000): Beck-Depressions- Inventar (BDI). In: Testhandbuch, 3. Auflage, Huber, Bern
11. Kraigher D, Ornter R, Eder H, Schindler S, Fischer G (2002): Retardiertes Morphinhydrochlorid in der Erhaltungstherapie Opioidabhängiger. Wien Klin Wochenschr 114, 904-910
12. Kraigher D, Jagsch R, Gombas W, Ortner R, Eder H, Primorac A, Fischer G (2005): Use of slow-release oral morphine for the treatment of opioid dependence. Eur Addict Res 11, 145-151
13. Krausz M (2003): Alternative Opioids - Maintenance treatment of opiate addicts with codeine and morphine. In: Helge Waal, Egil Haga (Hrsg.): Maintenance treatment of heroin addiction. Cappelen Akademisk Forlag, Oslo, S 121-128
14. Langrod J, Lowinson J, Ruiz P (1981): Methadone treatment and physical complaints: A clinical analysis. Int J Addict 16, 947-952
15. Mattick RP, Breen C, Kimber J, Davoli M (2003): Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence (Cochrane Review). In: The Cochrane Library, Issue 2.
16. Mattick RP, Kimber J, Breen C, Davoli M (2003): Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Cochrane Review). In: The Cochrane Library, Issue 2.
17. Mitchell TB, White JM, Somogyi AA, Bochner F (2003): Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence. Drug and Alcohol Dependence 72, 85-94
18. Mitchell TB, White JM, Somogyi AA, Bochner F (2004): Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence. Addiction 99, 940-945
19. Rosenblum A, Magura S, Joseph H (1991): Ambivalence toward methadone treatment among intravenous drug users. J Psychoactive Drugs 23, 21-27
20. Wang RI, Wiesen RL, Lamid S, Roh BL (1974): Rating the presence and severity of opiate dependence. Clin Pharmacol Ther 16, 653-658
21. von Zerssen D (1996): Beschwerden-Liste Selbstbeurteilungs-Skala. In: Collegium Internationale Psychiatriae Scalarum (Hrsg.): Internationale Skalen für Psychiatrie, 4. Auflage, Beltz-Test GmbH, Göttingen, S. 37-42